On ECHEMI
Home > Drugs > Acute intermittent porphyria in children
Acute intermittent porphyria in children
Acute intermittent porphyria (AIP), also known as hepatic porphyria and pyrroloporphyria, is a common type of porphyria. It was first reported by Gunther in 1911, and Waldenstrom fully described the disease based on extensive family studies in 1937. The disease is autosomal dominant. The main clinical manifestations include abdominal pain, peripheral nerve damage, hypothalamic lesions, mental disorders, photosensitive skin damage (photosensitive skin damage is an inflammatory reaction caused by exogenous photosensitive substances contacting the skin or entering the body through sun exposure. The former is called photocontact dermatitis and the latter is photodrug dermatitis) and large amounts of ALA and porphyrinogen excreted in the urine.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Children
  • Related symptoms:

    Restless nausea stomachache intestinal cramps oliguria
  • Concurrent disease:

Related Drugs
Sodium disodium thiothreitol for injection
Indication: This product is used to treat metal poisoning such as antimony, mercury, arsenic, lead, copper and hepatolenticular degeneration.
Manufacturer:

Shanghai SPH New ASIA Pharmaceutical Co., Ltd.

Sodium disodium thiothreitol for injection
Indication: This product is used to treat metal poisoning such as antimony, mercury, arsenic, lead, copper and hepatolenticular degeneration.
Manufacturer:

Shanghai SPH New ASIA Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.